What to Know Before Heading to the AACR Annual Meeting 2025
Key details about the program, registration, networking opportunities, and more, to help attendees prepare for the AACR Annual Meeting...
Daily Takeaways From the AACR Annual Meeting 2025: Monday, April 28
Takeaways from day four of the AACR Annual Meeting 2025 included data on one-dose HPV vaccination, technology advancing research,...
Daily Takeaways From the AACR Annual Meeting 2025: Sunday, April 27
Takeaways from day three of the AACR Annual Meeting 2025 included the inspiring Opening Ceremony, a panel on cancer...
Daily Takeaways From the AACR Annual Meeting 2025: Saturday, April 26
The second day of the AACR Annual Meeting 2025 included a 5K run/walk, the conclusion of the Educational Program,...
AACR Annual Meeting 2025 Plenaries: Cancer Evolution, Tumor Microenvironment, Drugging KRAS, and More
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research,...
Daily Takeaways From the AACR Annual Meeting 2025: Wednesday, April 30
Takeaways from the final day of the AACR Annual Meeting 2025 included the biggest discoveries presented, a look at...
AACR Annual Meeting 2025: What’s Next for the AACR 2025 NextGen Stars?
The 11 early-career researchers selected as AACR NextGen Star 2025 explain how their area of cancer research could progress...
From Students to Stars: Supporting Budding Scientists at the AACR Annual Meeting 2025
Special programs for high school and undergraduate students at the AACR Annual Meeting provide valuable opportunities for learning, networking,...
The Impact of Funding Cuts: AACR Annual Meeting 2025 Shows Why Cancer Research Matters
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts...
Daily Takeaways From the AACR Annual Meeting 2025: Tuesday, April 29
Takeaways from day 4 of the AACR Annual Meeting 2025 include declining breast cancer mortality, using liquid and tissue...
New Drugs on the Horizon Sessions Unveiled 12 Therapeutics at AACR Annual Meeting 2025
The New Drugs on the Horizon sessions at AACR Annual Meeting 2025 unveiled 12 novel cancer therapeutics and discussed...
How Does the AACR GSITA Program Benefit Young Cancer Researchers?
Four past recipients of the Global Scholar-in-Training Award (GSITA) share how their experience at the AACR Annual Meeting impacted...
Old, New, Borrowed, and Blue: Clinical Trial Results Highlight Therapeutic Approaches for Non-small Cell Lung Cancer
Clinical trial results reported at the AACR Annual Meeting 2025 showcased new therapeutic approaches for non-small cell lung cancer....
Meet The CheckPoints: A Band of Researchers and Oncologists Giving Cancer Treble
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
Senate Forum Examined the Ramifications of NIH Funding Cuts
A congressional forum hosted by Senators Tammy Baldwin and Peter Welch examined how NIH funding cuts could impact cancer...
Researchers Showcase How AACR Project GENIE Is Powering New Insights into Cancer Care
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...
FDA Approvals in Oncology: April-June 2025
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
Improving Cancer Care With Artificial Intelligence
At the AACR Annual Meeting 2025, a session on artificial intelligence in cancer care included ways of detecting skin...
Breakthroughs in the Blood: Leveraging Liquid Biopsy to Improve Cancer Care
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
Presidential Symposium Showcases Global Researchers Tackling Cancer Burden
During the Presidential Select Symposium at the AACR Annual Meeting 2025, Patricia M. LoRusso, DO, PhD(h), FAACR, led a...
Bloodlines Series: Mapping the Many Paths of Acute Myeloid Leukemia
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...
Pembrolizumab’s Perioperative Power in Head and Neck Cancer
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...
Frontiers in Cancer Science 2024: Singapore’s International Cancer Conference
The 16th Frontiers in Cancer Science conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
Editors’ Picks, April 2025: Brain Cancer Evolution, New Treatment Approaches, and More
For April 2025, the editors of AACR's 10 journals highlighted studies on evolution in glioblastoma, new cancer treatment approaches,...
Navigating the Meandering Path of Oncology Drug Development
At the AACR Annual Meeting 2025, experts offered strategies on how to overcome the challenges within the oncology drug...
New Treatment Strategies for Esophageal Cancer
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...